Italy1 robot tracked

MMI

MMI makes Symani, which is at stage 5 of 5: regulator-cleared or mass market.

Website: mmimicro.com
Based in: Italy
In our records as: MMI (Medical Microinstruments)
Latest milestone: 4 May 2026

01Robots

What MMI makes

Each robot's stage is worked out from its dated, sourced milestones by the same published rules, whoever the maker is.

SymaniMedical · Microsurgery robotStage 5 of 5 · Regulator-cleared or mass marketSymani is a surgical robot for microsurgery: stitching together blood and lymph vessels thinner than a millimetre. It scales down the surgeon's hand movements and filters out hand tremor.Used in hospitals in Europe, and in the US since 2024 (first US cases at Penn Presbyterian Medical Center).The full record

02Track record

Every dated event

4 May 2026Milestone
Baptist Health in Jacksonville, Florida did the first operation in a US study (REMIND) testing Symani microsurgery for Alzheimer's and similar brain diseases. The study plans 15 patients.
MassDevice, 4 May 2026Company-reported
1 Dec 2025Milestone
A new US billing code for lymph-to-vein bypass surgery with robot help (CPT 1019T) was created, taking effect 1 January 2026, so hospitals can bill for these operations.
MassDevice, 1 Dec 2025
1 May 2024Milestone
Penn Presbyterian Medical Center did the first two US operations with Symani, rebuilding damaged limbs.
MassDevice, 1 May 2024Company-reported
5 April 2024Regulator
The FDA cleared Symani through the De Novo route (DEN230032) for microsurgery on soft tissue.
MassDevice, 8 Apr 2024 (FDA record DEN230032)
April 2024Milestone
MMI said surgeons had used Symani in nearly 1,000 operations in Europe before the US clearance.
MassDevice, 8 Apr 2024Company-reported

03Money

How it's funded

Latest funding round we could confirm: MMI (Medical Microinstruments), maker of the Symani microsurgery robot, raised $125 million in a Series D round led by BioStar Capital. MedTech Dive, 9 Oct 2026

All robot stocks, funding and suppliers